Illumina's Grail partners with U.S. Department of Veterans Affairs to provide cancer detection test
Sundry Photography/iStock Editorial via Getty Images                 

Illumina's (NASDAQ:ILMN) subsidiaryÂ Grail said on Tuesday it had collaborated with the U.S. Department of Veterans Affairs to provide Galleri, a multi-cancer early detection blood test, to 10,000 veterans.
The collaboration will provide Galleri Test to 10 participating VA sites over the next three years across the U.S.
The eligible U.S. military veterans will be able to receive the Galleri test and can enroll in Grailâs Reflection study, the company said.
Also read -Â Illumina's Grail to offer cancer detection blood test to patients in Utah